Drug duo aims to supercharge weight loss
NCT ID NCT06373146
Summary
This study is testing whether adding a new investigational drug called mibavademab to an existing weight loss medication (tirzepatide) helps people lose more weight. About 392 adults with obesity will receive either the combination or tirzepatide alone for about 74 weeks. The main goal is to see if the two drugs together lead to greater weight loss than the single drug.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CTI Clinical Research Center
Cincinnati, Ohio, 45212, United States
-
Diablo Clinical Research, Inc.
Walnut Creek, California, 94598, United States
-
Hassman Research Institute Marlton Site
Marlton, New Jersey, 08053, United States
-
Irvine Clinical Research
Irvine, California, 92614, United States
-
Juno Research
Houston, Texas, 77040, United States
-
Lillestol Research
Fargo, North Dakota, 58104, United States
-
Northwest Clinical Research Center
Bellevue, Washington, 98007, United States
-
Solaris Clinical Research
Meridian, Idaho, 83646, United States
-
South Texas Clinical Research
Corpus Christi, Texas, 78404, United States
-
Tandem Clinical Research
Marrero, Louisiana, 70072, United States
-
Velocity Clinical Research - New Orleans
New Orleans, Louisiana, 70119, United States
-
Velocity Clinical Research, Dallas
Dallas, Texas, 75230, United States
-
Velocity Clinical Research, Gardena
Gardena, California, 90247, United States
-
Velocity Clinical Research, Los Angeles
Los Angeles, California, 90017, United States
-
Velocity Clinical Research, North Hollywood
North Hollywood, California, 91606, United States
-
Velocity Clinical Research, Panorama City
Van Nuys, California, 91405, United States
-
Velocity Clinical Research, Santa Ana
Santa Ana, California, 92704, United States
Conditions
Explore the condition pages connected to this study.